Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor–Biased Ligand in Adults With COVID-19
Wesley H. Self, Matthew S. Shotwell, Kevin W. Gibbs, et al.
JAMA (2023) Vol. 329, Iss. 14, pp. 1170-1170
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial
Suzana Margareth Lobo, Gaëtan Plantefève, Girish B. Nair, et al.
EClinicalMedicine (2024) Vol. 68, pp. 102383-102383
Open Access | Times Cited: 10
Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment
Mark C. Chappell
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1320-1337
Open Access | Times Cited: 17
The alternative renin–angiotensin system in critically ill patients: pathophysiology and therapeutic implications
Bruno Garcia, Alexander Zarbock, Rinaldo Bellomo, et al.
Critical Care (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 15
Renin–angiotensin–aldosterone system activation in plasma as marker for prognosis in critically ill patients with COVID-19: a prospective exploratory study
Katharina Krenn, Felix Kraft, Luana Mandroiu, et al.
Annals of Intensive Care (2025) Vol. 15, Iss. 1
Open Access
Incidence and pathological features of IgA nephropathy before and during the COVID-19 pandemic
Wen Liu, Ricong Xu, Di Wu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
GPCR drug discovery: new agents, targets and indications
José A. Lorente, Aleksandr V. Sokolov, Gavin Ferguson, et al.
Nature Reviews Drug Discovery (2025)
Closed Access
Modulation of the Renin-Angiotensin System against COVID-19: A path forward?
Serge Camelo, Waly Dioh, J. Pedro Teixeira, et al.
International Journal of Infectious Diseases (2025), pp. 107867-107867
Open Access
Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock
Daniel E. Leisman, Damian Handisides, Lakhmir S. Chawla, et al.
Annals of Intensive Care (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Dysfunction of the renin-angiotensin-aldosterone system in human septic shock
Christopher L. Schaich, Daniel E. Leisman, Marcia B. Goldberg, et al.
Peptides (2024) Vol. 176, pp. 171201-171201
Closed Access | Times Cited: 4
Autoantibodies Targeting G-Protein-Coupled Receptors: Pathogenetic, Clinical and Therapeutic Implications in Systemic Sclerosis
Marco Binda, Beatrice Moccaldi, Giovanni Civieri, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2299-2299
Open Access | Times Cited: 3
Angiotensin-(1–7) infusion in COVID-19 patients admitted to the ICU: a seamless phase 1–2 randomized clinical trial
Ana Luiza Valle Martins, Filippo Annoni, Filipe Alex da Silva, et al.
Annals of Intensive Care (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Role of the Renin-Angiotensin System in Long COVID’s Cardiovascular Injuries
Elena Cojocaru, Cristian Cojocaru, Cristiana-Elena Vlad, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 2004-2004
Open Access | Times Cited: 7
Angiotensin-(1–7) decreases inflammation and lung damage caused by betacoronavirus infection in mice
Érick Bryan de Sousa Lima, Antônio Felipe Silva Carvalho, Isabella Zaidan, et al.
Inflammation Research (2024)
Closed Access | Times Cited: 2
New insights into kidney disease after COVID-19 infection and vaccination: histopathological and clinical findings
Yebei Li, Yan Gong, Gaosi Xu
QJM (2023) Vol. 117, Iss. 5, pp. 317-337
Closed Access | Times Cited: 5
Renin-Angiotensin System Modulation in Adults With COVID-19
Robson A.S. Santos, Fabio Silvio Taccone, Filippo Annoni
JAMA (2023) Vol. 330, Iss. 7, pp. 663-663
Closed Access | Times Cited: 5
Effects of renin–angiotensin system blockers on outcomes from COVID-19: a systematic review and meta-analysis of randomized controlled trials
Matthew M.Y. Lee, Toru Kondo, Ross T. Campbell, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 10, Iss. 1, pp. 68-80
Open Access | Times Cited: 5
ADAM-17 Activity and Its Relation to ACE2: Implications for Severe COVID-19
Jiangming Sun, Andreas Edsfeldt, Joel Svensson, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5911-5911
Open Access | Times Cited: 1
Exploration of alive-and-ventilator free days as an outcome measure for clinical trials of Resuscitative interventions
Ari Moskowitz, Xianhong Xie, Michelle N. Gong, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0308033-e0308033
Open Access | Times Cited: 1
The statistical design and analysis of pandemic platform trials: Implications for the future
Christopher J. Lindsell, Matthew S. Shotwell, Kevin J. Anstrom, et al.
Journal of Clinical and Translational Science (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Intranasal liposomal angiotensin-(1-7) administration reduces inflammation and viral load in the lungs during SARS-CoV-2 infection in K18-hACE2 transgenic mice
Sabrina Mendes, Lays Cordeiro Guimarães, Pedro Augusto Carvalho Costa, et al.
Antimicrobial Agents and Chemotherapy (2024)
Closed Access | Times Cited: 1
Biomarkers of early SARS-CoV-2 infection before the onset of respiratory symptoms
Ooiean Teng, Amy M.L. Quek, Tuong Minh Nguyen, et al.
Clinical Microbiology and Infection (2023) Vol. 30, Iss. 4, pp. 540-547
Closed Access | Times Cited: 3
How COVID-19 Can Damage the Heart? – Association of Cardiac Injury with COVID-19: A Narrative Review
Catarina Gregório, Daniel Caldeira, Dulce Brito, et al.
Heart and Mind (2024)
Open Access
Lessons Learned from National Heart, Lung, and Blood Institute Covid-19 Clinical Trials
Sonia Thomas, Robert A. Harrington, Clyde W. Yancy, et al.
NEJM Evidence (2024) Vol. 3, Iss. 11
Closed Access
Shock prediction with dipeptidyl peptidase-3 and renin (SPiDeR) in hypoxemic patients with COVID-19
Laurence W. Busse, J. Pedro Teixeira, Christopher L. Schaich, et al.
Journal of Critical Care (2024) Vol. 85, pp. 154950-154950
Closed Access
Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia
Sean P. Collins, Matthew S. Shotwell, Jeffrey R. Strich, et al.
JAMA Network Open (2024) Vol. 7, Iss. 12, pp. e2448215-e2448215
Closed Access
Page 1 - Next Page

Scroll to top